Acknowledgments
The authors would like to thank Dr. Char Witmer (The Children’s Hospital of Philadelphia) for providing guidance and feedback on designing the survey and reviewing manuscript, Dr. Robert Klaassen (Children’s Hospital of Eastern Ontario) for his guidance as a research lead in the primary author’s institution, Dr. Donna Johnston (Children’s Hospital of Eastern Ontario) and Dr. Yaser Mohammad (Children’s Hospital of Eastern Ontario) for their valuable feedback.
The authors would also like to thank members of the Saudi Arabia Pediatric Hematology Oncology Society (SAPHOS) for their support and consideration in taking part in the survey.
References :
1. Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children’s hospitals in the United States from 2001 to 2007. Pediatrics . 2009. doi:10.1542/peds.2009-0768
2. Witmer C, Raffini L. Treatment of venous thromboembolism in pediatric patients. Blood . 2020;135(5):335-343. doi:10.1182/blood.2019001847
3. Jones S, Butt W, Monagle P, Cain T, Newall F. The natural history of asymptomatic central venous catheter–related thrombosis in critically ill children. Blood . 2019. doi:10.1182/blood-2018-05-849737
4. Talbott GA, Winters WD, Bratton SL, O’rourke PP. A Prospective Study of Femoral Catheter-Related Thrombosis in Children. Arch Pediatr Adolesc Med . 1995. doi:10.1001/archpedi.1995.02170150068012
5. Mitchell LG, Andrew M, Abshire T, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: Results of the Prophylactic Antithrombin Replacement in Kids with Acute. Cancer . 2003. doi:10.1002/cncr.11042
6. Monagle P. Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation? Thromb Res . 2019. doi:10.1016/j.thromres.2018.07.016
7. Baglin T, Gray E, Greaves M, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol . 2010. doi:10.1111/j.1365-2141.2009.08022.x
8. Chalmers E, Ganesen V, Liesner R, et al. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol . 2011. doi:10.1111/j.1365-2141.2010.08543.x
9. National Institute for Health and Care Excellence. Venous thromboembolic diseases : diagnosis , management and thrombophilia testing. NICE Guidel . 2015.
10. Choosing Wisely. American Society of Hematology-American Society of Pediatric Hematology/Oncology. Don’t order thrombophilia testing on children with venous access (i.e., peripheral or central) associated thrombosis in the absence of a positive family history. Released December 9, 2019. https://www.choosingwisely.org/clinician-lists/ash-aspho-avoid-thrombophilia-testing-in-children-without-positive-family-history/. Accessed July 8, 2020
11. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest . 2012. doi:10.1378/chest.11-2308
12. Brandão LR, Shah N, Shah PS. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children. Cochrane Database Syst Rev . 2014. doi:10.1002/14651858.CD005982.pub2
13. Avila ML, Amiri N, Stanojevic S, et al. Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?Blood . 2018. doi:10.1182/blood-2017-10-811216
14. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: Treatment of pediatric venous thromboembolism. Blood Adv . 2018. doi:10.1182/bloodadvances.2018024786
15. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. A metadata-driven methodology and workflow process for providing translational research informatics support, J Biomed Inform. J Biomed Inf . 2009. doi:10.1016/j.jbi.2008.08.010.Research
16. Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners.J Biomed Inform . 2019. doi:10.1016/j.jbi.2019.103208
17. Echigoya R, Okamoto H, Uchino H, et al. Incidence and outcome of asymptomatic deep vein thrombosis in critically ill patients: a prospective cohort study. Crit Care . 2015. doi:10.1186/cc14406
18. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood . 1987. doi:10.1182/blood.v70.1.165.bloodjournal701165
19. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. J Pediatr Hematol Oncol . 1990. doi:10.1097/00043426-199021000-00019
20. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood . 1988. doi:10.1182/blood.v72.5.1651.bloodjournal7251651
21. Goldenberg NA, Abshire T, Blatchford PJ, et al. Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): Pilot/feasibility phase findings. J Thromb Haemost . 2015. doi:10.1111/jth.13038
22. Witmer CM, Sauck E, Raffini LJ. A survey of pediatric hematology/oncology specialists regarding management of central line associated venous thrombosis. Pediatr Blood Cancer . 2017;64(7):7-10. doi:10.1002/pbc.26383
23. Massicotte P, Julian JA, Gent M, et al. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: The PROTEKT trial. Thromb Res . 2003. doi:10.1016/S0049-3848(03)00099-9
24. Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies - A randomized, controlled study. Acta Paediatr Int J Paediatr . 2006. doi:10.1080/08035250600729092
25. Schroeder AR, Axelrod DM, Silverman NH, Rubesova E, Merkel E, Roth SJ. A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery*. 2010;11(4):489-495. doi:10.1097/PCC.0b013e3181ce6e29
26. Vidal E, Sharathkumar A, Glover J, Faustino EVS. Central venous catheter-related thrombosis and thromboprophylaxis in children: A systematic review and meta-analysis. J Thromb Haemost . 2014. doi:10.1111/jth.12598
27. Pelland-Marcotte MC, Amiri N, Avila ML, Brandão LR. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev . 2020. doi:10.1002/14651858.CD005982.pub3